Smith MR - Search Results

1

Adequate staging for uterine cancer can be performed through Pfannenstiel incisions.

Horowitz NS, Powell MA, Drescher CW, Smith MR, Atwood M, Mate TA, Peters WA. Horowitz NS, et al. Among authors: smith mr. Gynecol Oncol. 2003 Mar;88(3):404-10. doi: 10.1016/s0090-8258(02)00166-x. Gynecol Oncol. 2003. PMID: 12648594

2

Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma.

Horowitz NS, Peters WA 3rd, Smith MR, Drescher CW, Atwood M, Mate TP. Horowitz NS, et al. Among authors: smith mr. Obstet Gynecol. 2002 Feb;99(2):235-40. doi: 10.1016/s0029-7844(01)01672-6. Obstet Gynecol. 2002. PMID: 11814503

3

Cisplatin and adriamycin combination chemotherapy for uterine stromal sarcomas and mixed mesodermal tumors.

Peters WA 3rd, Rivkin SE, Smith MR, Tesh DE. Peters WA 3rd, et al. Among authors: smith mr. Gynecol Oncol. 1989 Sep;34(3):323-7. doi: 10.1016/0090-8258(89)90166-2. Gynecol Oncol. 1989. PMID: 2767523

4

Three-consecutive-day topotecan is an active regimen for recurrent epithelial ovarian cancer.

Brown JV 3rd, Peters WA 3rd, Rettenmaier MA, Graham CL, Smith MR, Drescher CW, Micha JP. Brown JV 3rd, et al. Among authors: smith mr. Gynecol Oncol. 2003 Feb;88(2):136-40. doi: 10.1016/s0090-8258(02)00021-5. Gynecol Oncol. 2003. PMID: 12586592 Clinical Trial.

5

Intraperitoneal P-32 is not an effective consolidation therapy after a negative second-look laparotomy for epithelial carcinoma of the ovary.

Peters WA 3rd, Smith MR, Cain JM, Lee RB, Yon JL Jr. Peters WA 3rd, et al. Among authors: smith mr. Gynecol Oncol. 1992 Nov;47(2):146-9. doi: 10.1016/0090-8258(92)90098-4. Gynecol Oncol. 1992. PMID: 1468691 Clinical Trial.

6

Adenocarcinoma of the uterine cervix metastatic to lymph nodes.

Cohn DE, Peters WA 3rd, Muntz HG, Wu R, Greer BE, Tamimi HK, Drescher CW, Smith MR, Yon JL, Schmidt R, Goff BA. Cohn DE, et al. Among authors: smith mr. Am J Obstet Gynecol. 1998 Jun;178(6):1131-7. doi: 10.1016/s0002-9378(98)70313-8. Am J Obstet Gynecol. 1998. PMID: 9662291

7

A phase I trial of a 3-day topotecan Q 21 days for recurrent epithelial cancers of the ovary, fallopian tube, and peritoneum.

Brown JV 3rd, Peters WA 3rd, Rettenmaier MA, Karlan BY, Dillman RA, Smith MR, Drescher CW, Micha JP. Brown JV 3rd, et al. Among authors: smith mr. Gynecol Oncol. 2000 Dec;79(3):495-8. doi: 10.1006/gyno.2000.6006. Gynecol Oncol. 2000. PMID: 11104627 Clinical Trial.

8

Rectal prolapse in women with other defects of pelvic floor support.

Peters WA 3rd, Smith MR, Drescher CW. Peters WA 3rd, et al. Among authors: smith mr. Am J Obstet Gynecol. 2001 Jun;184(7):1488-94; discussion 1494-5. doi: 10.1067/mob.2001.114853. Am J Obstet Gynecol. 2001. PMID: 11408872

9

Cisplatin, doxorubicin hydrochloride, and cyclophosphamide followed by radiotherapy in high-risk endometrial carcinoma.

Smith MR, Peters WA 3rd, Drescher CW. Smith MR, et al. Am J Obstet Gynecol. 1994 Jun;170(6):1677-81; discussion 1681-2. doi: 10.1016/s0002-9378(94)70340-x. Am J Obstet Gynecol. 1994. PMID: 8203425 Clinical Trial.

10

CA-125. Use as a tumor marker with mixed mesodermal tumors of the female genital tract.

Peters WA 3rd, Bagley CM, Smith MR. Peters WA 3rd, et al. Among authors: smith mr. Cancer. 1986 Dec 15;58(12):2625-7. doi: 10.1002/1097-0142(19861215)58:12<2625::aid-cncr2820581213>3.0.co;2-a. Cancer. 1986. PMID: 3022909

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,175 results

Search Page

Filters